Stroke-like episodes in adult mitochondrial disease
Yi Shiau Ng1, Gráinne S Gorman1
1Wellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.
Abstract:
Stroke-like episode is a paroxysmal neurological manifestation which affects a specific group of patients with mitochondrial disease. Focal-onset seizures, encephalopathy, and visual disturbances are prominent findings associated with stroke-like episodes, with a predilection for the posterior cerebral cortex. The most common cause of stroke-like episodes is the m.3243A>G variant in MT-TL1 gene followed by recessive POLG variants. This chapter aims to review the definition of stroke-like episode and delineate the clinical phenomenology, neuroimaging and EEG findings typically seen in patients. In addition, several lines of evidence supporting neuronal hyper-excitability as the key mechanism of stroke-like episodes are discussed. The management of stroke-like episodes should focus on aggressive seizure management and treatment for concomitant complications such as intestinal pseudo-obstruction. There is no robust evidence to prove the efficacy of l-arginine for both acute and prophylactic settings. Progressive brain atrophy and dementia are the sequalae of recurrent stroke-like episode, and the underlying genotype in part predicts prognosis.
Insights
Stroke-like episodes in mitochondrial disease present with seizures and encephalopathy, often linked to MT-TL1 or POLG gene variants. Management focuses on seizure control and complications, with genotype influencing prognosis.
Area of Science:
- Neurology
- Genetics
- Mitochondrial Diseases
Background:
- Stroke-like episodes are neurological events in mitochondrial disease patients.
- Key symptoms include focal seizures, encephalopathy, and visual disturbances, often affecting the posterior cerebral cortex.
- Common genetic causes are the m.3243A>G variant in MT-TL1 and POLG variants.
Conclusions:
- Stroke-like episodes are a significant manifestation of mitochondrial disease, influenced by specific genetic variants.
- Prognosis is partly determined by genotype, with recurrent episodes leading to brain atrophy and dementia.
- Current evidence does not support l-arginine for acute or prophylactic treatment.
Related Concept Videos
ATP Synthase: Mechanism
Mitochondrial Membranes
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Mitochondrial Precursor Proteins
Most of the mitochondrial...
Mitral Stenosis II: Clinical features and Diagnostic Tests
Animal Mitochondrial Genetics


